Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pitarangsi, C., Echeverria, P., Whitmire, R., Tirapat, C., Formal, S., Dammin, G. J., & Tingtalapong, M. (1982). Enteropathogenicity of Aeromonas hydrophila and Plesiomonas shigelloides: prevalence among individuals with and without diarrhea in Thailand. Infection and Immunity, 35(2), 666–673.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces (CCUG, Pitarangsi1982), clinical sources (wound, blood - CCUG), fresh and marine waters and animals
DNA G+C(%): 58-62
|
Opt. T: 28℃
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
ampicillin: Res
aztreonam: Sens
carbenicil: R(30; disc)
piperacillin: Res
imipenem: Sens
|
cefepime: Sens
cefixime: Sens
cefotaxime: Sens
ceftazidime: Sens
cefuroxime: Sens
cephalothin: R(30; disc)
|
amikacin: Sens
gentamicin: Sens
tobramycin: Sens
|
|
levofloxacin: Sens
ofloxacin: Sens
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
minocycline: Sens
tetracycline: Sens
|
|
|
chloramphenicol: Sens
co-trimoxazole: Res
|
colistin: Var(MIC50): 4; disc), MIC90: Var(4; disc
|